06929.HK
OrbusNeich Medical Group Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 3.83
−0.52%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 364.1M | 180.5M | 164.1M | 153.9M | 136.8M |
| Cost of Revenue | 115.5M | 58.0M | 49.6M | 47.4M | 44.4M |
| Gross Profit | 248.6M | 122.4M | 114.5M | 106.5M | 92.5M |
| Operating Expenses | |||||
| R&D Expense | 33.8M | 16.2M | 17.0M | 14.8M | 14.5M |
| SG&A Expense | 136.8M | 67.4M | 62.7M | 54.8M | 55.1M |
| General & Admin Expense | 37.3M | 24.9M | 25.3M | 18.9M | 22.6M |
| Selling & Marketing Expense | 61.4M | 42.5M | 37.4M | 35.9M | 32.6M |
| Other Expenses | 591.6K | (872.0K) | 2.5M | (3.1M) | 1.8M |
| Total Operating Expenses | 171.2M | 82.7M | 82.3M | 66.6M | 71.4M |
| Cost and Expenses | 286.7M | 140.7M | 131.9M | 113.9M | 115.8M |
| Operating Income (EBIT) | 77.4M | 39.7M | 32.2M | 39.9M | 21.1M |
| Non-Operating | |||||
| Interest Income | 17.8M | 8.9M | 11.9M | 10.7M | 2.4M |
| Interest Expense | 212.8K | 168.0K | 219.0K | 142.0K | 1.5M |
| Net Interest Income | 17.6M | 8.7M | 11.7M | 10.5M | 924.0K |
| Other Non-Op Income/Expense | 15.0M | 7.3M | 10.2M | 9.7M | 719.0K |
| Non-Operating Income (excl Interest) | (1.3M) | 397.0K | (2.6M) | (9.8M) | (2.2M) |
| EBT (Pre-Tax Income) | 92.4M | 47.1M | 42.4M | 49.6M | 21.8M |
| Income Tax Expense | 7.8M | 5.1M | 2.6M | 4.6M | 3.3M |
| Bottom Line | |||||
| Net Income | 84.3M | 41.9M | 39.7M | 45.1M | 18.5M |
| Earnings from Cont. Ops | 84.6M | 42.0M | 39.8M | 45.1M | 18.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 84.3M | 41.9M | 39.7M | 45.1M | 18.5M |
| Per Share | |||||
| Basic EPS | HK$0.10 | HK$0.05 | HK$0.05 | HK$0.05 | HK$0.03 |
| Diluted EPS | HK$0.10 | HK$0.05 | HK$0.05 | HK$0.05 | HK$0.03 |
| Revenue Per Share | HK$0.44 | HK$0.22 | HK$0.20 | HK$0.18 | HK$0.19 |
| Shares | |||||
| Basic Shares Outstanding | 823.3M | 824.8M | 825.7M | 833.0M | 724.1M |
| Diluted Shares Outstanding | 825.3M | 825.5M | 826.3M | 833.0M | 776.4M |
| Profitability Metrics | |||||
| EBITDA | 87.1M | 42.8M | 36.8M | 54.0M | 27.1M |
| D&A | 8.3M | 3.4M | 1.9M | 4.2M | 3.9M |
| EBIT | 78.7M | 39.3M | 34.8M | 49.8M | 23.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026